Statistics about Health, Pharma & Medtech in United States
Statistics
- Harrow liabilities 2019-2023
- Healthy Extracts Inc. operating profit 2015-2018
- Quest Diagnostics revenue 2019-2023
- Quest Diagnostics total equity 2019-2023
- Seagen Inc. revenue 2018-2022
- Q32 Bio Inc. net income 2019-2023
- Harrow operating profit 2019-2023
- Hst Global operating profit 2019-2023
- Heska Corp operating profit 2018-2022
- American Clean Resources Group revenue 2019-2023
- Quest Diagnostics operating profit 2019-2023
- Quest Diagnostics net cash 2019-2023
- Forma Therapeutics Holdings, Inc. total equity 2018-2021
- Finch Therapeutics Group net income 2020-2023
- Sigilon Therapeutics revenue 2020-2022
- Foghorn Therapeutics revenue 2020-2023
- Genethera net income 2013-2017
- Paratek Pharmaceuticals, Inc. total equity 2018-2022
- Genethera net cash 2017-2021
- Genethera liabilities 2017-2021
- Foghorn Therapeutics total assets 2019-2023
- Genethera total assets 2017-2021
- Abbvie total assets 2019-2023
- Foghorn Therapeutics liabilities 2019-2023
- Amgen operating profit 2019-2023
- Genethera total equity 2017-2021
- Foghorn Therapeutics net income 2019-2020
- Amgen total assets 2019-2023
- Sana Biotechnology liabilities 2020-2023
- Foghorn Therapeutics operating profit 2019-2023
- Scopus Biopharma operating profit 2019-2022
- Provectus Biopharmaceuticals total assets 2019-2023
- Prevalence of health conditions in the U.S. 2024
- Usage of Cannabis products in the U.S. 2024
- Medicinova net cash 2019-2023
- Personalis total equity 2019-2023
- Foghorn Therapeutics total equity 2019-2023
- Fulgent Genetics total assets 2019-2023
- Fulgent Genetics gross profit 2019-2023
- Fulgent Genetics net cash 2019-2023
- Forma Therapeutics Holdings, Inc. net cash 2019-2021
- Forma Therapeutics Holdings, Inc. operating profit 2019-2021
- Scopus Biopharma total assets 2019-2022
- Fulgent Genetics total equity 2019-2023
- Fulgent Genetics operating profit 2019-2023
- Fulgent Genetics liabilities 2019-2023
- Forma Therapeutics Holdings, Inc. liabilities 2019-2021
- Fulgent Genetics net income 2019-2023
- Genethera operating profit 2017-2021
- Fulgent Genetics revenue 2019-2023
- Sana Biotechnology total assets 2020-2023
- Paxmedica total equity 2020-2023
- Provectus Biopharmaceuticals total equity 2019-2023
- Scopus Biopharma net cash 2019-2022
- Petros Pharmaceuticals total equity 2019-2023
- Sana Biotechnology net cash 2019-2023
- Ptc Therapeutics total equity 2019-2023
- Foghorn Therapeutics net cash 2019-2023
- Q32 Bio Inc. net cash 2019-2023
- Healthy Extracts Inc. liabilities 2016-2020
- Generation Bio net cash 2019-2023
- Gene Biotherapeutics net cash 2014-2020
- Hero Technologies liabilities 2014-2022
- Ginkgo Bioworks Holdings, Inc. total equity 2019-2022
- Ginkgo Bioworks Holdings, Inc. total assets 2019-2023
- Hepion Pharmaceuticals, Inc. liabilities 2019-2023
- Ginkgo Bioworks Holdings, Inc. liabilities 2019-2023
- Ginkgo Bioworks Holdings, Inc. operating profit 2019-2023
- Gene Biotherapeutics total equity 2016-2020
- Gene Biotherapeutics liabilities 2016-2020
- Processa Pharmaceuticals, Inc. total assets 2019-2023
- Processa Pharmaceuticals, Inc. total equity 2019-2023
- Hoth Therapeutics operating profit 2019-2023
- Ginkgo Bioworks Holdings, Inc. net income 2019-2023
- Ginkgo Bioworks Holdings, Inc. revenue 2019-2023
- Gene Biotherapeutics total assets 2016-2020
- Gene Biotherapeutics operating profit 2016-2020
- Hillevax operating profit 2021-2023
- Gene Biotherapeutics gross profit 2011-2013
- American Clean Resources Group liabilities 2019-2023
- Gene Biotherapeutics revenue 2011-2013
- Sigilon Therapeutics liabilities 2020-2022
- Ginkgo Bioworks Holdings, Inc. net cash 2019-2023
- Processa Pharmaceuticals, Inc. net cash 2019-2023
- Silo Pharma, Inc. liabilities 2019-2023
- Pure Harvest Corporate Group gross profit 2015-2020
- Generation Bio net income 2019-2023
- Generation Bio total equity 2019-2023
- Hero Technologies total assets 2014-2022
- Generation Bio liabilities 2019-2023
- Hepion Pharmaceuticals, Inc. total assets 2019-2023
- Generation Bio total assets 2019-2023
- Progyny revenue 2019-2023
- Hoth Therapeutics net cash 2019-2023
- Shuttle Pharmaceuticals Holdin liabilities 2021-2023
- Hillevax net cash 2021-2023
- Protalix Biotherapeutics revenue 2019-2023
- Pure Harvest Corporate Group revenue 2019-2020
- Protalix Biotherapeutics net income 2020-2023
- Hero Technologies net cash 2014-2022